Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.

por Kenter, G., Bonfrer, J. M., Heintz, A. P.
Publicado 1987

Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.

por Bruning, P. F., Bonfrèr, J. M., Hart, A. A.
Publicado 1985

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.

por Bonfrer, J. M., Korse, C. M., Nieweg, O. E., Rankin, E. M.
Publicado 1998

Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease

por Zuetenhorst, J M, Korse, C M, Bonfrer, J M G, Bakker, R H, Taal, B G
Publicado 2004

Tamoxifen, serum lipoproteins and cardiovascular risk.

por Bruning, P. F., Bonfrer, J. M., Hart, A. A., de Jong-Bakker, M., Linders, D., van Loon, J., Nooyen, W. J.
Publicado 1988

Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites

por Van Doornum, G J J, Korse, C M, Buning-Kager, J C G M, Bonfrer, J M G, Horenblas, S, Taal, B G, Dillner, J
Publicado 2003

Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlot...

por Kappers, I, Vollebergh, M A, van Tinteren, H, Korse, C M, Nieuwenhuis, L L, Bonfrer, J M G, Klomp, H M, van Zandwijk, N, van den Heuvel, M M
Publicado 2010